Business Context and Reporting Period
This Form 8-K filing by Bristol-Myers Squibb Company (BMS) reports a corporate event dated November 5, 2009, filed on November 12, 2009. The report details a debt issuance by Mead Johnson Nutrition Company (MJN), an indirect subsidiary of BMS.
Key Financial Metrics
The filing focuses on the creation of a direct financial obligation rather than operating performance metrics like revenue or profit.
- Total Debt Issued: $1.5 billion aggregate principal amount.
- Net Proceeds: Approximately $1,482.7 million.
- Debt Repayment: Proceeds were used to repay approximately $1,482.7 million of intercompany debt owed to a BMS subsidiary. An additional $200 million was borrowed under a revolving credit agreement to repay the remaining balance, leaving only $50 million of the original intercompany debt outstanding.
- Interest Rates: 3.50% (2014 Notes), 4.90% (2019 Notes), and 5.90% (2039 Notes).
- Liquidity Impact: The transaction reduced intercompany debt obligations significantly, utilizing both new external debt and existing cash/credit facilities.
Material Changes
The primary material change is the restructuring of MJN's debt profile:
- New Obligations: MJN issued three tranches of unsecured senior notes totaling $1.5 billion.
- Debt Reduction: MJN reduced its intercompany debt to BMS from approximately $1,744.2 million to $50 million.
- Guarantees: The new notes are guaranteed by Mead Johnson & Company (MJC), a direct wholly-owned subsidiary of MJN.
Outlook, Risks, and Unusual Items
Registration Rights and Contingencies: MJN entered into a Registration Rights Agreement with Citigroup and Morgan Stanley. MJN must use reasonable best efforts to register the notes for exchange or resale within 270 days of issuance. Failure to do so will trigger an obligation to pay additional interest on the notes.
Covenants and Default: The notes include customary covenants limiting consolidation, mergers, asset sales, liens, and sale-leaseback transactions. They contain standard events of default.
Redemption and Change of Control: MJN may redeem the notes at its option. In the event of a change of control, holders have the right to require MJN to purchase the notes at 101% of principal plus accrued interest.
Investor Verification Checklist
- Verify the exact terms of the Registration Rights Agreement and the 270-day deadline for the exchange offer or shelf registration.
- Confirm the remaining $50 million intercompany debt balance and its specific terms as a floating rate note due 2014.
- Review the full text of the Indenture (Exhibit 4.1) and Supplemental Indenture (Exhibit 4.2) for specific covenant limitations on MJN's operations.
- Assess the impact of the new fixed-rate debt on MJN's future interest expense compared to the previous intercompany debt structure.